Back to Home
Research & Insights

Axis Direct Labs Blog

Original articles on COA verification, independent third-party testing, and handling of research-use-only compounds — published to help researchers understand documentation before they handle a vial.

Visual research guide

Tesamorelin & Retatrutide

Two pathways, different outcomes, and an important evidence gap. Swipe through the ten slides.

Tesamorelin and retatrutide: two metabolic research pathways
Body weight and visceral fat are not the same
Tesamorelin: the GH–IGF-1 pathway
What tesamorelin research found
Retatrutide: the triple-receptor pathway
What phase 2 retatrutide research found
The scale does not tell the whole story
Why researchers discuss them together
The combination has an evidence gap
The research takeaway

Slide 1 of 10 · Tap image to enlarge

Educational content—not medical advice. Different mechanisms do not establish combination safety or benefit.

Industry Feed

Laboratory Chain Custody Process Explained

Laboratory Chain Custody Process Explained

A certificate of analysis can only support confidence when the material tested can be connected to the material received, stored, and released. The laboratory chain custody process creates that connection. It records each transfer of responsibility and condition of a sample or batch, turning a quality claim into a traceable record.

For research-focused purchasers, chain of custody is not administrative overhead. It is the evidence trail that helps establish whether a batch identifier, analytical result, storage history, and supporting document all refer to the same research material. When a discrepancy appears, that trail determines whether the issue can be investigated efficiently or remains an unsupported question.

What Is a Laboratory Chain Custody Process?

A laboratory chain custody process is a controlled documentation system that tracks a material from receipt through handling, testing, storage, release, and, when applicable, disposal or retention. Each custody event should identify what moved, who accepted responsibility, when the event occurred, and whether the material's condition was acceptable.

The term is often associated with forensic evidence, but the underlying control applies broadly in analytical and research settings. A laboratory may use it for incoming raw materials, retained samples, reference standards, finished research products, stability samples, and specimens submitted for analysis.

The required level of detail depends on risk. A low-risk internal transfer may be documented in a laboratory information system with user credentials and timestamps. A shipment received from an outside party may require package-condition photos, temperature-device review, a signed receipt, and a documented quarantine decision. The purpose is not to create paperwork for its own sake. It is to preserve identity, integrity, and accountability.

Why Chain of Custody Matters for Research Materials

A batch number on a label is useful only when it remains tied to records generated throughout the material's lifecycle. Without custody controls, a laboratory can face basic but consequential uncertainty: Was the tested aliquot drawn from the correct container? Was the material exposed to unsuitable conditions? Was a sample relabeled after a transfer? Which lot does a reported result actually represent?

For research peptides and other sensitive materials, those questions can affect the value of every downstream record. Identity testing, purity analysis, mass data, chromatograms, and a COA each provide meaningful information. Yet their value depends on sample traceability. Analytical data cannot correct a broken connection between the sample tested and the batch released.

A documented process also supports exception management. Packages can arrive damaged. Seals can be compromised. Labels can be incomplete. Temperature indicators can suggest an excursion. Controlled custody allows personnel to isolate the affected material, record the observed condition, notify the appropriate quality function, and determine whether release, retesting, rejection, or further review is warranted.

Core Records in the Laboratory Chain Custody Process

Chain of custody should be designed around records that can be reviewed, reconciled, and retrieved. Whether the laboratory uses paper forms, barcode scanning, or an electronic quality system, the record should preserve the same essential controls.

At a minimum, a custody record generally captures these distinct elements:

  • Unique material, sample, or batch identifier
  • Date and time of receipt, transfer, sampling, or return
  • Names or authenticated user identities for the releasing and receiving parties
  • Storage location and applicable environmental condition
  • Observed condition, seal status, and any deviations or exceptions

The identifier is the anchor. It should be assigned or confirmed at receipt and maintained across every related label, test request, instrument file, retained sample, COA, and release record. Free-text descriptions alone are vulnerable to spelling variations and ambiguous naming. A controlled batch or sample code is more reliable because it can be reconciled across systems.

Time is equally significant. A record showing that a sample was transferred is incomplete if it cannot establish when the transfer occurred. Timestamps help evaluate hold times, storage exposure, testing sequence, and the timing of any deviation. Electronic systems can improve this control through system-generated timestamps and role-based access, but only if user accounts are managed properly and audit trails are retained.

From Receiving to Release: A Controlled Workflow

Receipt and intake

The process begins before a sample enters routine inventory. Receiving personnel should compare the shipment against the expected order or submission record, confirm the package is addressed correctly, and document the external condition. If cold-chain handling is required, receipt time and any available temperature evidence should be reviewed promptly.

Materials with an unresolved discrepancy should not move directly into available stock. A clearly defined quarantine status prevents accidental use while the discrepancy is assessed. Quarantine is a control state, not a conclusion. The material may later be accepted, rejected, returned, or tested under an approved deviation procedure.

Identification, labeling, and storage

Once accepted for intake, the material should receive a durable identifier or a verified link to its existing batch identifier. The identifier needs to remain readable under actual storage conditions. Labels should not obscure original supplier information, expiration or retest dates, or safety markings where applicable.

Storage records should show where the material is located and any required conditions. For temperature-sensitive research materials, the custody record should connect to storage-monitoring evidence where possible. A freezer location alone does not demonstrate appropriate control if there is no record of temperature performance, alarm response, or excursion review.

Sampling and analytical transfer

Sampling is a high-risk handoff because it creates a new physical portion of the original material. The parent container, sampled amount, sample container, analyst or sampler, date, and destination should be documented. If the sample is split among analytical methods or laboratories, each aliquot must remain traceable to the parent batch and to its individual test assignment.

A common weak point is informal bench handling. A container temporarily set aside without a label, a handwritten abbreviation that does not match the batch record, or an undocumented transfer between analysts can interrupt traceability. Controlled work areas, contemporaneous entries, and reconciliation at the end of the activity reduce this exposure.

Test reporting and batch release

Analytical results should be reviewed against the correct sample and method before a COA or internal report is issued. Reviewers should be able to trace the reported result back to the test request, sample identifier, instrument output, and source batch. If a result is invalidated, repeated, or replaced, the reason and approval should remain visible in the quality record.

Release should be performed by authorized personnel under defined acceptance criteria. The release decision may rely on identity, purity, assay, moisture, microbiological attributes, appearance, or other specifications relevant to the material. What matters for custody is that the released batch is unambiguously the batch supported by the reviewed documentation.

Where Chain of Custody Commonly Fails

Most failures are ordinary operational gaps rather than dramatic losses. Labels may be printed with the wrong lot number. A sample may be transferred before the receiving record is completed. A spreadsheet may be edited without version history. A COA may be posted using a product name but without the batch number needed for independent verification.

These issues are preventable when procedures are practical enough for daily use. Overly complicated forms encourage delayed entries and workarounds. Under-documented workflows leave no basis for investigation. The right balance is a process that captures critical control points with clear ownership, required fields, and defined exception paths.

Training should address the reason behind each requirement, not merely the form fields. Personnel who understand that a custody gap can disconnect a COA from a specific batch are more likely to stop, document, and escalate an unusual event. Periodic internal review should test real records from receipt through release rather than simply confirming that a procedure exists.

What Purchasers Should Look For

A purchaser generally will not see a supplier's full internal chain-of-custody file. Nor should routine commercial documentation disclose controlled internal details. However, transparent suppliers can provide meaningful evidence that their documentation system is batch-specific and organized.

Look for a batch or lot number that is visible on the product labeling and matched on the COA. Confirm that the COA identifies the material, reports relevant test attributes, and is available through a clear verification process. Records should not rely solely on generic product-level claims that cannot be tied to the specific item received.

Axis Direct Labs organizes batch-level verification and comprehensive quality documentation so purchasers can review the records associated with their research materials. That access is most useful when buyers retain their own receipt, product label, and batch details. Together, those items preserve the handoff from supplier documentation to the research environment.

A well-maintained custody trail does not eliminate every laboratory risk. It does provide a disciplined basis for answering the questions that matter when quality is reviewed: what was handled, which batch it came from, who controlled it, and what documentation supports it. Retain those identifiers and records at the point of receipt, because traceability is strongest when it continues beyond the supplier's facility.

Research Use Only · Not for Human Consumption